How should paroxysmal supraventricular tachycardia be managed?

Management of Paroxysmal Supraventricular Tachycardia

For hemodynamically stable PSVT, attempt vagal maneuvers first, followed immediately by intravenous adenosine (91% effective), and refer all patients with documented PSVT to cardiac electrophysiology for catheter ablation, which achieves 94-98% cure rates and is now first-line therapy to prevent recurrence. 1

Acute Management Algorithm

Hemodynamically Unstable Patients

• Perform immediate synchronized electrical cardioversion if the patient exhibits hypotension, altered mental status, acute heart failure, or ongoing chest pain suggesting ischemia. 2, 1

Hemodynamically Stable Patients

Step 1: Vagal Maneuvers

• Perform the modified Valsalva maneuver (43% effective) as first-line intervention—this is safer and more effective than carotid sinus massage, particularly in elderly patients. 1, 3
• Termination with vagal maneuvers confirms re-entrant tachycardia involving AV nodal tissue (AVNRT or AVRT). 4, 5

Step 2: Intravenous Adenosine

• Administer IV adenosine if vagal maneuvers fail—this achieves conversion in 91% of patients within 3 minutes. 1
• Adenosine is safer than calcium channel blockers when the ECG diagnosis is uncertain, as it will not cause hemodynamic collapse in ventricular tachycardia. 6

Step 3: Calcium Channel Blockers

• Use IV diltiazem or verapamil if adenosine is contraindicated or ineffective—verapamil terminates acute PSVT in approximately 93% of cases. 5, 7
• Diltiazem typically converts PSVT to sinus rhythm within 3 minutes of bolus administration in 88% of patients. 7

Critical Contraindications

Never use adenosine or calcium channel blockers in:

• Wolff-Parkinson-White syndrome with atrial fibrillation—these agents can accelerate conduction down the accessory pathway and precipitate ventricular fibrillation. 7, 2
• Use IV procainamide instead if the patient is hemodynamically stable, or immediate cardioversion if unstable. 2

Diagnostic Confirmation

Obtain a 12-lead ECG immediately to:

• Confirm narrow complex tachycardia (QRS <120 ms) with regular rhythm at 150-250 bpm. 3
• Identify pre-excitation patterns (delta waves) suggesting WPW syndrome, which mandates immediate electrophysiology referral. 5
• Distinguish PSVT from ventricular tachycardia—never rely on automated ECG interpretation, which is frequently erroneous. 5

Key ECG features:

• P waves typically hidden within the QRS complex in AVNRT. 3
• P waves following the QRS with R-P interval >70 ms suggests AVRT with an accessory pathway. 3

Long-Term Management Strategy

First-Line: Catheter Ablation

• Refer all patients with documented PSVT to cardiac electrophysiology for catheter ablation—this is now recommended as first-line therapy for recurrent, symptomatic PSVT. 1, 8
• Single-procedure success rates are 94.3-98.5% with <5% recurrence and <1% risk of complete heart block. 5, 1
• Ablation is particularly appropriate for young patients with structurally normal hearts who prefer definitive cure over lifelong medication. 5

Pharmacologic Suppression (Second-Line)

• Beta-blockers (metoprolol, atenolol) or non-dihydropyridine calcium channel blockers (diltiazem, verapamil) may be used for chronic suppression if ablation is declined or contraindicated. 5, 8
• Confirm absence of significant bradycardia (resting heart rate ≥50 bpm) before initiating beta-blockers. 5
• Avoid digoxin as first-line therapy—it is less effective than beta-blockers or calcium channel blockers and carries higher toxicity risk, especially with renal impairment. 5

Antiarrhythmic Agents

• Never start Class Ic (flecainide, propafenone) or Class III (sotalol, amiodarone) antiarrhythmics empirically without documented sustained arrhythmia and exclusion of structural heart disease due to substantial pro-arrhythmic risk. 5
• Class Ic agents are absolutely contraindicated in patients with prior myocardial infarction. 5

Mandatory Specialist Referral Criteria

Immediate electrophysiology referral is required for:

• Any patient with Wolff-Parkinson-White syndrome (pre-excitation on baseline ECG with paroxysmal palpitations) due to risk of sudden death. 5
• Wide complex tachycardia of unknown origin documented on any rhythm strip. 5
• Severe symptoms during episodes including syncope, presyncope, or marked dyspnea. 5
• Drug-resistant or drug-intolerant PSVT despite optimal medical therapy. 5
• Patient preference for definitive cure rather than lifelong medication. 5

Monitoring and Follow-Up

For patients awaiting ablation or on medical therapy:

• Discontinue all caffeine, alcohol, and nicotine immediately—these are common triggers that facilitate premature beats initiating PSVT. 5, 9
• Review all medications for QT-prolonging drugs, stimulants (cocaine, amphetamines), and over-the-counter supplements. 5
• Consider event recorder or loop recorder for patients with weekly episodes to document rhythm during symptoms—this has superior diagnostic yield compared to 24-48 hour Holter monitoring. 5

Critical Pitfalls to Avoid

• Never dismiss syncope occurring with palpitations—this may signal ventricular arrhythmia, complete AV block, or underlying structural heart disease requiring urgent evaluation. 5
• Do not attribute palpitations to anxiety without thorough cardiac evaluation and appropriate pharmacologic trial. 5
• Avoid carotid sinus massage in elderly patients—the Valsalva maneuver is safer and more effective. 3
• Do not use calcium channel blockers or adenosine in pre-excited atrial fibrillation—this can be lethal. 7, 2
• Obtain echocardiography for all documented PSVT to exclude structural heart disease (valvular disease, cardiomyopathy, left atrial enlargement) that may influence management. 5

Special Considerations

Tachycardia-mediated cardiomyopathy:

• Can develop in 1% of patients with persistent PSVT and fast ventricular response lasting weeks to months, emphasizing the importance of timely definitive treatment. 5, 1

Polyuria:

• Occurs in approximately 15% of SVT patients due to atrial natriuretic peptide release from atrial contraction against a closed AV valve—this symptom supports the diagnosis of sustained supraventricular arrhythmia. 4, 5